John Levine

This study is testing a drug called ruxolitinib as the first treatment for acute graft-versus-host disease (GVHD), a serious complication that can occur after a bone marrow transplant. Researchers want to see if ruxolitinib alone works as well as steroid-free therapy for lower-ri…